Stocks and Investing Stocks and Investing
Thu, January 5, 2023
[ 12:00 AM ] - WOPRAI
Tony Butler Initiated (BCAB) at Strong Buy and Held Target at $25 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Michael Roxland Downgraded (BERY) to Hold and Held Target at $70 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Vincent Caintic Upgraded (BFH) to Buy and Held Target at $64 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Daniel Tamayo Downgraded (BFST) to Hold on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Jeffrey Bernstein Upgraded (USFD) to Buy and Increased Target to $43 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Daniel Tamayo Downgraded (VBTX) to Hold on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Sung Ji Nam Initiated (VCYT) at Buy and Held Target at $33 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Samad Samana Downgraded (VERX) to Hold and Increased Target to $15 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Brian Bittner Downgraded (WEN) to Hold on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Jeffrey Bernstein Maintained (WEN) at Buy with Increased Target to $28 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Zachary Fadem Maintained (W) at Sell with Decreased Target to $30 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Geoff Meacham Initiated (AMLX) at Strong Buy and Held Target at $50 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Jeffrey Bernstein Maintained (WING) at Buy with Decreased Target to $167 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Jay Sole Downgraded (VSCO) to Strong Sell on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Roger Read Maintained (VLO) at Buy with Increased Target to $140 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Rob Owens Maintained (VRNS) at Hold with Increased Target to $23 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Gallo Downgraded (VRNS) to Hold and Decreased Target to $26 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Sam Reid Maintained (VRM) at Hold with Decreased Target to $80 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Samad Samana Downgraded (VRNT) to Hold and Decreased Target to $40 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Abbie Zvejnieks Downgraded (WWW) to Hold and Decreased Target to $13 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Thome Downgraded (YMAB) to Hold on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Robyn Karnauskas Maintained (ABBV) at Strong Buy with Increased Target to $180 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
James Lee Maintained (ABNB) at Hold with Decreased Target to $110 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Quinn Bolton Maintained (ACLS) at Strong Buy with Increased Target to $100 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Sung Ji Nam Initiated (BNGO) at Buy and Held Target at $40 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Jeffrey Bernstein Maintained (BLMN) at Buy with Decreased Target to $24 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Edward Yruma Downgraded (BIRD) to Hold and Decreased Target to $80 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Jeffrey Bernstein Maintained (BJRI) at Sell with Increased Target to $24 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Darrin Peller Maintained (ADP) at Sell with Increased Target to $225 on, Jan 5th, 2023
[ 12:00 AM ] - WOPRAI
Sung Ji Nam Initiated (ADPT) at Buy and Held Target at $15 on, Jan 5th, 2023

Sung Ji Nam Initiated (ADPT) at Buy and Held Target at $15 on, Jan 5th, 2023


Published on 2024-10-28 00:45:38 - WOPRAI, Sung Ji Nam
  Print publication without navigation


Sung Ji Nam of Scotiabank, Initiated "Adaptive Biotechnologies Corporation" (ADPT) at Buy and Held Target at $15 on, Jan 5th, 2023.

Sung has made no other calls on ADPT in the last 4 months.



There are 2 other peers that have a rating on ADPT. Out of the 2 peers that are also analyzing ADPT, 1 agrees with Sung's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $16 on, Monday, November 7th, 2022


This is the rating of the analyst that currently disagrees with Sung

  • David Westenberg of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $14 on, Wednesday, December 21st, 2022
Contributing Sources